Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1136/heartjnl-2024-324331 | DOI Listing |
J Am Coll Cardiol
January 2025
Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address:
Heliyon
November 2024
Graduate Institute of Biomedical Optomechatronics, Taipei Medical University, Taipei, 110, Taiwan.
Industrial wastewater management is a significant global challenge. Sludge microbiota from swine farms may play a crucial role in enhancing wastewater treatment processes, thereby reducing water pollution from industrial activities. A deeper understanding of this complex community could lead to innovative approaches for improving wastewater treatment methods.
View Article and Find Full Text PDFJ Optom
October 2023
Ocular Surface and Contact Lens Research Laboratory, Faculty of Optics and Optometry, Universidade de Santiago de Compostela, Spain; Clínica Oftalmológica Dr. Parafita, Ribeira, Spain.
Purpose: To study topographic epithelial and total corneal thickness changes in myopic subjects undergoing successful orthokeratology treatment in connection with the objective assessment of contact lens decentration.
Methods: A prospective-observational and non-randomized study in 32 Caucasian myopic eyes undergoing Ortho-k for 3 months. Total, epithelial, and stromal thicknesses were studied before and after Ortho-k treatment, using optical coherence tomography with anterior segment application software.
Heart
August 2024
Dept of Cardiology, Westmead Hospital, Westmead, New South Wales, Australia
Int Rev Neurobiol
July 2024
Department of Basic and Oral Biology, School of Dentistry of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, SP, Brazil; National Institute for Science and Technology, Translational Medicine, University of Sao Paulo, Ribeirao Preto, SP, Brazil; Center for Cannabinoid Research, Mental Health Building, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, Brazil.
Chronic pain presents significant personal, psychological, and socioeconomic hurdles, impacting over 30% of adults worldwide and substantially contributing to disability. Unfortunately, current pharmacotherapy often proves inadequate, leaving fewer than 70% of patients with relief. This shortfall has sparked a drive to seek alternative treatments offering superior safety and efficacy profiles.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!